As interest in diabetes and weight-loss medications such as Ozempic, Wegovy, and Zepbound surged in recent years, supplement manufacturers responded by launching a number of GLP-1-branded products including pills, powders, drops, and patches
Patients perception of injectable therapy include perceived difficultly to use and fear of injections
Medicare is effectively testing whether obesity medications can become a benefit for its broad base of participants, but because this program operates outside normal Part D coverage and its $50 payments do not count toward beneficiaries annual out-of-pocket totals, access after 2027 will depend on further revisions to either continue the program in its current form or make a more substantial effort to integrate it into existing Medicare services, Alex Beene, a financial literacy instructor for the University of Tennessee at Martin, told Newsweek
In 2026, none of the Bridge drugs are subject to an MFP
Regardless of which route you choose, all weight loss injections require a prescription from a licensed clinician who reviews your health history, sets the correct dose, and monitors your progress throughout treatment
